Featured Content
Monoclonal Antibodies: Beyond the Platform in Manufacturing
The BPI editors review some state-of-the-art alternatives in upstream and downstream monoclonal antibodies for drug substance bioprocessing as well as drug-product manufacturing.China’s Emergence in Global Biopharma Manufacturing: Trends in the Chinese Biopharma Industry
Sponsored This four-part educational series highlights key trends emerging in China biopharmaceuticals, using select content from BioPlan Associates’ 2018 report on the biopharmaceutical industry in China.MilliporeSigma plans to ramp up filtration manufacture in NH
MilliporeSigma intends to add an additional 38,500 square feet of manufacturing space at its site in New Hampshire to support demand for filtration devices. The bioprocessing business unit of Germany’s Merck KGaA, MilliporeSigma, has revealed it is planning to expand a site in Jaffrey, New Hampshire that makes filtration equipment for the life sciences industry. “To meet the future demands of the bioprocessing market, we are in the approval process to expand the facility with additional cleanroom and lab space…